Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
Clinical trial NCT02311621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02311621
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-25
- Primary completion
- 2023-11-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.